ES8407051A1 - Procedimiento para la preparacion de derivados de imidazo-i,2-c,3,4-e pirimidina. - Google Patents

Procedimiento para la preparacion de derivados de imidazo-i,2-c,3,4-e pirimidina.

Info

Publication number
ES8407051A1
ES8407051A1 ES522617A ES522617A ES8407051A1 ES 8407051 A1 ES8407051 A1 ES 8407051A1 ES 522617 A ES522617 A ES 522617A ES 522617 A ES522617 A ES 522617A ES 8407051 A1 ES8407051 A1 ES 8407051A1
Authority
ES
Spain
Prior art keywords
pyrazolo
pyrimidines
imidazo
production
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES522617A
Other languages
English (en)
Other versions
ES522617A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of ES8407051A1 publication Critical patent/ES8407051A1/es
Publication of ES522617A0 publication Critical patent/ES522617A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C07D231/40—Acylated on said nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS DE IMIDAZO 1,2-CPIRAZOLO 3,4-EPIRIMIDINA.CONSIS TE EN HACER REACCIONAR UN COMPUESTO DE FORMULA (II) CON ANION COMO YODURO O AZIDA, PARA OBTENER UN COMPUESTO DE FORMULA (I) Y SUS SALES FARMACEUTICAMENTE ACEPTABLES, DONDE R1, R2, R3, R4, R5 SON H, ALCOHILO DE C 1 A 6 O ALCOHILO FLUORADO DE C 1 A 3; X ES UN GRUPO DE FORMULA (II) O NHCHR5CHR4OH. LA REACCION SE EFECTUA EN UN DISOLVENTE NO REACTIVO COMO CETONA, SULFOXIDO DE DIMETILO N,N-DIASCOHILACETAMIDA Y OTROS Y A TEMPERATURA ELEVADA.SE UTILIZAN PARA TRATAR SICOSIS EN MAMIFEROS.
ES522617A 1982-05-24 1983-05-23 Procedimiento para la preparacion de derivados de imidazo-i,2-c,3,4-e pirimidina. Granted ES522617A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/381,484 US4469868A (en) 1982-05-24 1982-05-24 Alkylimidazo[1,2-c]pyrazolo[3,4-e]pyrimidines

Publications (2)

Publication Number Publication Date
ES8407051A1 true ES8407051A1 (es) 1984-09-01
ES522617A0 ES522617A0 (es) 1984-09-01

Family

ID=23505215

Family Applications (4)

Application Number Title Priority Date Filing Date
ES522617A Granted ES522617A0 (es) 1982-05-24 1983-05-23 Procedimiento para la preparacion de derivados de imidazo-i,2-c,3,4-e pirimidina.
ES529373A Expired ES8506004A1 (es) 1982-05-24 1984-02-01 Procedimiento para la preparacion de derivados de imidazo (1, 2-c) pirazolo (3, 4-e) pirimidina
ES529372A Expired ES8506019A1 (es) 1982-05-24 1984-02-01 Procedimiento para la preparacion de derivados de imidazo (1, 2-c) pirazolo (3, 4-e) pirimidina
ES529371A Expired ES8506315A1 (es) 1982-05-24 1984-02-01 Procedimiento para la preparacion de derivados de imidazo (1, 2-c) pirazolo (3, 4-e) pirimidina

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES529373A Expired ES8506004A1 (es) 1982-05-24 1984-02-01 Procedimiento para la preparacion de derivados de imidazo (1, 2-c) pirazolo (3, 4-e) pirimidina
ES529372A Expired ES8506019A1 (es) 1982-05-24 1984-02-01 Procedimiento para la preparacion de derivados de imidazo (1, 2-c) pirazolo (3, 4-e) pirimidina
ES529371A Expired ES8506315A1 (es) 1982-05-24 1984-02-01 Procedimiento para la preparacion de derivados de imidazo (1, 2-c) pirazolo (3, 4-e) pirimidina

Country Status (22)

Country Link
US (1) US4469868A (es)
EP (1) EP0095289B1 (es)
JP (1) JPS58210087A (es)
KR (1) KR870000931B1 (es)
AR (1) AR240941A1 (es)
AT (1) ATE24510T1 (es)
AU (1) AU553708B2 (es)
CA (1) CA1210393A (es)
DE (1) DE3368635D1 (es)
DK (1) DK161968C (es)
ES (4) ES522617A0 (es)
FI (1) FI74012C (es)
GR (1) GR79262B (es)
HK (1) HK102989A (es)
HU (1) HU187913B (es)
IE (1) IE55111B1 (es)
IL (1) IL68360A0 (es)
NO (1) NO160444C (es)
NZ (1) NZ204321A (es)
PH (1) PH18454A (es)
PT (1) PT76745B (es)
ZA (1) ZA832637B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988000192A1 (en) * 1986-06-26 1988-01-14 Warner-Lambert Company 5-SUBSTITUTED PYRAZOLO[4,3-d]PYRIMIDIN-7-ONES
JP2008520749A (ja) * 2004-11-23 2008-06-19 レディ ユーエス セラピューティックス， インコーポレイテッド 新規二環式ヘテロ環化合物、その調製のためのプロセス、およびその新規二環式ヘテロ環化合物を含む組成物
CN103467471A (zh) 2005-06-06 2013-12-25 武田药品工业株式会社 有机化合物
WO2008070095A1 (en) 2006-12-05 2008-06-12 Intra-Cellular Therapies, Inc. Novel uses
MX2011005936A (es) 2008-12-06 2011-12-16 Intra Cellular Therapies Inc Compuestos organicos.
JP2012526810A (ja) 2009-05-13 2012-11-01 イントラ−セルラー・セラピーズ・インコーポレイテッド 有機化合物
TW201206937A (en) 2010-05-31 2012-02-16 Intra Cellular Therapies Inc Organic compounds
WO2011153138A1 (en) 2010-05-31 2011-12-08 Intra-Cellular Therapies, Inc. Organic compounds
US9802937B2 (en) * 2011-04-21 2017-10-31 Origenis Gmbh Substituted pyrazolo{4,3-D}pyrimidines as kinase inhibitors
WO2014060112A1 (en) 2012-10-19 2014-04-24 Origenis Gmbh Pyrazolo[4,3-d]pyrimidines as kinase inhibitors
WO2014127331A1 (en) 2013-02-17 2014-08-21 Intra-Cellular Therapies, Inc. Novel uses
EP3479825B1 (en) 2013-03-15 2021-02-17 Intra-Cellular Therapies, Inc. Pde1 inhibitors for use in the treatment and/or prevention of cns or pns diseases or disorders
MX2015013042A (es) 2013-03-15 2016-05-05 Intra Cellular Therapies Inc Compuestos organicos.
ES2732442T3 (es) 2014-06-20 2019-11-22 Intra Cellular Therapies Inc Compuestos orgánicos
US10285992B2 (en) 2014-08-07 2019-05-14 Intra-Cellular Therapies, Inc. Combinations of PDE1 inhibitors and NEP inhibitors and associated methods
JP6591530B2 (ja) 2014-08-07 2019-10-16 イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． 有機化合物
US10150774B2 (en) 2014-09-17 2018-12-11 Intra-Cellular Therapies, Inc. Compounds and methods
WO2017172795A1 (en) 2016-03-28 2017-10-05 Intra-Cellular Therapies, Inc. Novel compositions and methods
EP3509589B1 (en) 2016-09-12 2021-11-17 Intra-Cellular Therapies, Inc. Novel uses
JP7401442B2 (ja) 2018-01-31 2023-12-19 イントラ－セルラー・セラピーズ・インコーポレイテッド 新規使用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH422807A (de) * 1963-08-16 1966-10-31 Wander Ag Dr A Verfahren zur Herstellung von Imidazo- und Pyrimidochinazolinen
US3313815A (en) * 1964-05-04 1967-04-11 Sterling Drug Inc 8-chloropyrazolo-[1, 5-c]quinazoline derivatives and methods of preparing same
US3309369A (en) * 1966-04-11 1967-03-14 Wander Ag Dr A Imidazo- and pyrimido-quinazolines
US3594379A (en) * 1968-09-16 1971-07-20 Sandoz Ag 2,3-dihydroimidazo(1,2-c)quinazolines
DE2058501A1 (de) * 1970-11-27 1972-05-31 Bayer Ag Verfahren zur Herstellung von neuen N-verbrueckten bicyclischen Heteroaromaten
GB1347493A (en) * 1971-02-11 1974-02-27 Aspro Nicholas Ltd Benzazine derivatives
US3984556A (en) * 1973-01-19 1976-10-05 Sandoz, Inc. Alkyl-substituted-tricyclic quinazolinones for lowering blood pressure
JPS516993A (en) * 1974-07-05 1976-01-20 Dainippon Pharmaceutical Co Adeninjudotaino seiho
JPS5398997A (en) * 1977-02-09 1978-08-29 Sumitomo Chem Co Ltd Fused pyridine derivertives and process for their preparation
US4206123A (en) * 1977-10-31 1980-06-03 Mccall John M Isothiochroman
US4247553A (en) * 1977-10-31 1981-01-27 The Upjohn Company Methods of treating psychosis
US4250181A (en) * 1977-10-31 1981-02-10 The Upjohn Company Methods of treating psychosis
US4192803A (en) * 1978-09-15 1980-03-11 American Cyanamid Company 5H-Pyrrolo[2,1-c][1,4]benzodiazepine derivatives
DK460879A (da) * 1978-11-01 1980-05-02 Wellcome Found Fremgangsmaade til fremstilling af 9-(3-(3,5-cisdimethylpiperazino)propyl)carbazol et salt heraf eller et solvat af et saadant salt
CH643263A5 (de) * 1979-05-11 1984-05-30 Sandoz Ag Benzodiazepine, ihre herstellung und verwendung.
HU178523B (en) * 1979-05-18 1982-05-28 Egyt Gyogyszervegyeszeti Gyar Process for preparing new pyrazolo-quinazoline derivatives
US4230707A (en) * 1979-08-27 1980-10-28 Warner-Lambert Company Oxo-pyrido[1,2-a]thienopyrimidine compounds and methods for their production
US4358456A (en) * 1980-05-03 1982-11-09 John Wyeth & Brother Limited Antipsychotic piperidinomethyl-indole derivatives
US4396770A (en) * 1982-04-09 1983-08-02 Hoechst-Roussel Pharmaceuticals Inc. 1-[3-(6-Fluoro-1,2-benzisoxazol-3-yl)propyl]-4-hydroxy-4-phenylpiperidines
US4352811A (en) * 1981-11-12 1982-10-05 Hoechst-Roussel Pharmaceuticals Inc. 3-(1-Substituted-4-piperidyl)-1,2-benzisoxazoles
US4374245A (en) * 1982-04-09 1983-02-15 Hoechst-Roussel Pharmaceuticals Inc. 8-[3-(6-Fluoro-1,2-benzisoxazol-3-yl)propyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one
US4409230A (en) * 1982-04-09 1983-10-11 Hoechst-Roussel Pharmaceuticals Inc. Pharmaceutical compositions and methods employing 8-[3-(6-fluoro-1,2-benzisoxazol-3-yl)propyl]-1-phenyl-1,3,8-triazaspiro-[4.]decan-4-one and derivatives thereof
US4415581A (en) * 1982-04-09 1983-11-15 Hoechst-Roussel Pharmaceuticals Inc. 1-[3-6-Fluoro-1,2-benzisoxazol-3-yl)propyl]-4-hydroxy-4-phenylpiperidines to treat psychoses
US4390544A (en) * 1982-04-09 1983-06-28 Hoechst-Roussel Pharmaceuticals Inc. {1-[3-(6-Fluoro-1,2-benzisoxazol-3-yl)propyl]-4-(2-oxo-1-benzimidazolinyl}p
US5059699A (en) * 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol

Also Published As

Publication number Publication date
CA1210393A (en) 1986-08-26
IL68360A (en) 1986-10-31
JPH0320395B2 (es) 1991-03-19
ES529373A0 (es) 1985-06-16
KR870000931B1 (ko) 1987-05-11
AU553708B2 (en) 1986-07-24
PT76745B (en) 1986-04-21
JPS58210087A (ja) 1983-12-07
AR240941A1 (es) 1991-03-27
US4469868A (en) 1984-09-04
NO160444B (no) 1989-01-09
NO160444C (no) 1989-04-19
EP0095289A3 (en) 1984-09-05
EP0095289B1 (en) 1986-12-30
FI831742A0 (fi) 1983-05-18
ES8506004A1 (es) 1985-06-16
DK161968C (da) 1992-02-03
EP0095289A2 (en) 1983-11-30
NZ204321A (en) 1986-06-11
AU1342783A (en) 1983-12-01
ES529371A0 (es) 1985-07-01
PT76745A (en) 1983-06-01
IE55111B1 (en) 1990-06-06
ES529372A0 (es) 1985-06-16
NO831792L (no) 1983-11-25
ES8506315A1 (es) 1985-07-01
ZA832637B (en) 1984-01-25
DK227183A (da) 1983-11-25
DE3368635D1 (en) 1987-02-05
FI74012B (fi) 1987-08-31
DK227183D0 (da) 1983-05-20
PH18454A (en) 1985-07-18
ATE24510T1 (de) 1987-01-15
HU187913B (en) 1986-03-28
DK161968B (da) 1991-09-02
IE830822L (en) 1983-11-24
HK102989A (en) 1990-01-05
ES522617A0 (es) 1984-09-01
ES8506019A1 (es) 1985-06-16
FI831742L (fi) 1983-11-25
IL68360A0 (en) 1986-10-31
KR840004756A (ko) 1984-10-24
GR79262B (es) 1984-10-22
FI74012C (fi) 1987-12-10
AR240941A2 (es) 1991-03-27

Similar Documents

Publication Publication Date Title
ES8407051A1 (es) Procedimiento para la preparacion de derivados de imidazo-i,2-c,3,4-e pirimidina.
ES8603477A1 (es) Procedimiento para preparar una 1h-imidazo (4, 5-c) quinolin-4-amina
ES8308327A1 (es) Un procedimiento para la preparacion de nuevos derivados biciclicos de piridin-5-ona.
EP0500143A3 (en) Pharmaceutical composition comprising an aminoglycoside phosphate
ES8802387A1 (es) Procedimiento para preparar (1,2,4)-triazolo (1,5-c) quinazolinas
IL68133A (en) 1-substituted-7-oxo-1h,7h-pyrazolo(1,5-a)pyrimidine-6-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
HUT47276A (en) Process for producing pyrazolo/1,5-a/pyrimidine derivatives and pharmaceutical compositions containing them
IL70485A (en) Imidazo(1,5-a)pyridine derivatives,their preparation and pharmaceutical compositions containing them
DE3366467D1 (en) Imidazo(1,2-a)pyrimidines and their salts, process and intermediates for their preparation, their use as medicaments and compositions containing them
ES8104287A1 (es) Un procedimiento para la preparacion de pirido (1,2-a) piri-midinas substituidas
AU569532B2 (en) Pyrazolo(3,4,5- kl) acridines
ZA839092B (en) New pharmacologically active pyrazolopyridines
ZA80578B (en) New 2-amino-8-cyclopropyl-5-oxo-5,8-dihydro-pyrido((2,3-d))pyrimidine-6-carboxylic acid compounds,their production and their medicinal use
GB2114129B (en) Substituted 1,3,4-thiadiazolo(3,2-a) pyrimidines and process for their preparation
DE3065963D1 (en) Pyrazolo (5,1-b) quinazolin-9(4h)-one derivatives, process for their preparation and pharmaceutical compositions containing them
ES8505357A1 (es) Un procedimiento para la preparacion de derivados de carboxi-tiazolo (3,2-a) pirimidina nuevos
ZA831611B (en) Substituted 1h-pyrazolo(1,5-a)pyrimidines and process for their preparation
EP0147774A3 (en) 4,7-dimethyl-2-(4-pyridinyl)-1,2,4-triazolo(1,5-a)pyrimidine-5(4h)-one
IL63159A (en) Indolo(2',3',3,4)pyrido(2,1-b)quinazoline-5-ones,a process for the preparation thereof and pharmaceutical compositions containing them
IL70424A0 (en) Pyrazolo(4,3-b)(1,4)oxazines,their preparation and pharmaceutical compositions containing them
IL84556A (en) 2-substituted cycloalka(b)pyrazolo(3,4-d)pyridin-3-one derivatives,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960506